Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Development and external validation of a nomogram for predicting the overall survival of patients with stage II nasopharyngeal carcinoma after curative treatment.

He SS, Wang CT, Peng ZW, Ren YF, Lu LX, Chen RW, Liang SB, Wang Y, Chen Y.

Cancer Manag Res. 2019 May 10;11:4403-4412. doi: 10.2147/CMAR.S202151. eCollection 2019.

2.

Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.

Li J, Chen S, Peng S, Liu Y, Xing S, He X, Chen H.

Int J Biol Sci. 2018 Apr 5;14(5):549-556. doi: 10.7150/ijbs.24374. eCollection 2018.

3.

Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment.

Liang W, Shen G, Zhang Y, Chen G, Wu X, Li Y, Li A, Kang S, Yuan X, Hou X, Huang P, Huang Y, Zhao H, Tian Y, Zhao C, Zhang L.

Chin J Cancer. 2016 Nov 25;35(1):98.

4.

Establishing and applying nomograms based on the 8th edition of the UICC/AJCC staging system to select patients with nasopharyngeal carcinoma who benefit from induction chemotherapy plus concurrent chemoradiotherapy.

Xu C, Chen YP, Liu X, Li WF, Chen L, Mao YP, Zhang Y, Guo R, Zhou GQ, Tang LL, Lin AH, Sun Y, Ma J.

Oral Oncol. 2017 Jun;69:99-107. doi: 10.1016/j.oraloncology.2017.04.015. Epub 2017 May 2.

PMID:
28559028
5.

External validity of a prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma based on the 8th edition of the AJCC/UICC staging system: a retrospective cohort study.

OuYang PY, You KY, Zhang LN, Xiao Y, Zhang XM, Xie FY.

Cancer Commun (Lond). 2018 Sep 3;38(1):55. doi: 10.1186/s40880-018-0324-x.

6.

An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study.

Li XH, Chang H, Xu BQ, Tao YL, Gao J, Chen C, Qu C, Zhou S, Liu SR, Wang XH, Zhang WW, Yang X, Zhou SL, Xia YF.

Cancer Med. 2017 Jan;6(1):310-319. doi: 10.1002/cam4.947. Epub 2016 Nov 10.

7.

Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma.

Tang LQ, Li CF, Li J, Chen WH, Chen QY, Yuan LX, Lai XP, He Y, Xu YX, Hu DP, Wen SH, Peng YT, Zhang L, Guo SS, Liu LT, Guo L, Wu YS, Luo DH, Huang PY, Mo HY, Xiang YQ, Sun R, Chen MY, Hua YJ, Lv X, Wang L, Zhao C, Cao KJ, Qian CN, Guo X, Zeng YX, Mai HQ, Zeng MS.

J Natl Cancer Inst. 2015 Oct 14;108(1). pii: djv291. doi: 10.1093/jnci/djv291. Print 2016 Jan.

PMID:
26467665
8.

Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.

Pan JJ, Ng WT, Zong JF, Lee SW, Choi HC, Chan LL, Lin SJ, Guo QJ, Sze HC, Chen YB, Xiao YP, Kan WK, O'Sullivan B, Xu W, Le QT, Glastonbury CM, Colevas AD, Weber RS, Lydiatt W, Shah JP, Lee AW.

Cancer. 2016 Nov 15;122(21):3307-3315. doi: 10.1002/cncr.30198. Epub 2016 Jul 19.

9.

Development and validation of nomogram based on SIRI for predicting the clinical outcome in patients with nasopharyngeal carcinomas.

Chen Y, Jiang W, Xi D, Chen J, Xu G, Yin W, Chen J, Gu W.

J Investig Med. 2019 Mar;67(3):691-698. doi: 10.1136/jim-2018-000801. Epub 2018 Aug 20.

10.

Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy.

Zeng L, Guo P, Li JG, Han F, Li Q, Lu Y, Deng XW, Zhang QY, Lu TX.

Oncotarget. 2015 Nov 17;6(36):39373-83. doi: 10.18632/oncotarget.5781.

11.

The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.

Wan Y, Tian L, Zhang G, Xin H, Li H, Dong A, Liang Y, Jing B, Zhou J, Cui C, Chen M, Sun Y, Xie C, Liu L, Shao Y.

Radiother Oncol. 2019 Feb;131:35-44. doi: 10.1016/j.radonc.2018.11.001. Epub 2018 Dec 20.

PMID:
30773185
12.

Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control study.

Li Y, Chen QY, Tang LQ, Liu LT, Guo SS, Guo L, Mo HY, Chen MY, Guo X, Cao KJ, Qian CN, Zeng MS, Bei JX, Shao JY, Sun Y, Tan J, Chen S, Ma J, Zhao C, Mai HQ.

BMC Cancer. 2017 Aug 24;17(1):567. doi: 10.1186/s12885-017-3552-6.

13.

The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.

Miao J, Xiao W, Wang L, Han F, Wu H, Deng X, Guo X, Zhao C.

J Cancer Res Clin Oncol. 2017 Jul;143(7):1263-1273. doi: 10.1007/s00432-017-2360-3. Epub 2017 Feb 28.

PMID:
28247035
14.

Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study.

Guo SS, Tang LQ, Chen QY, Zhang L, Liu LT, Guo L, Mo HY, Luo DH, Huang PY, Xiang YQ, Sun R, Chen MY, Wang L, Lv X, Zhao C, Guo X, Cao KJ, Qian CN, Zeng MS, Bei JX, Hong MH, Shao JY, Sun Y, Ma J, Mai HQ.

Oncotarget. 2016 May 17;7(20):29739-48. doi: 10.18632/oncotarget.8828.

15.

Development and validation of a nomogram for predicting survival in Chinese han patients with resected colorectal cancer.

Li J, Gu J, Ma X, Li X, Liu X, Kang F, Xue F.

J Surg Oncol. 2018 Nov;118(6):1034-1041. doi: 10.1002/jso.25213. Epub 2018 Sep 9.

PMID:
30196534
16.

Chemotherapy use and survival in stage II nasopharyngeal carcinoma.

Pan XB, Huang ST, Chen KH, Zhu XD.

Oncotarget. 2017 Oct 11;8(60):102573-102580. doi: 10.18632/oncotarget.21751. eCollection 2017 Nov 24.

17.

Posterior cervical lymph node metastasis as the valuable prognostic factor for stage IVA/IVB nasopharyngeal carcinoma treated with induction chemotherapy followed by concurrent chemo-radiotherapy.

Thephamongkhol K, Setakornnukul J, Rojwatkarnjana S, Chansilpa Y.

Int J Biol Markers. 2014 Dec 9;29(4):e387-94. doi: 10.5301/jbm.5000106.

PMID:
25198554
18.

Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.

Wu S, Xia B, Han F, Xie R, Song T, Lu L, Yu W, Deng X, He Q, Zhao C, Xie C.

PLoS One. 2015 Aug 6;10(8):e0134491. doi: 10.1371/journal.pone.0134491. eCollection 2015.

19.

Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.

Chen QY, Wen YF, Guo L, Liu H, Huang PY, Mo HY, Li NW, Xiang YQ, Luo DH, Qiu F, Sun R, Deng MQ, Chen MY, Hua YJ, Guo X, Cao KJ, Hong MH, Qian CN, Mai HQ.

J Natl Cancer Inst. 2011 Dec 7;103(23):1761-70. doi: 10.1093/jnci/djr432. Epub 2011 Nov 4.

PMID:
22056739
20.

Involvement of both cervical lymph nodes and retropharyngeal lymph nodes has prognostic value for N1 patients with nasopharyngeal carcinoma.

Shi Q, Shen C, Kong L, Wang X, Ding J, Gao Y, Xu T, Hu C.

Radiat Oncol. 2014 Jan 6;9:7. doi: 10.1186/1748-717X-9-7.

Supplemental Content

Support Center